BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 9931257)

  • 1. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
    Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
    Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
    McGrath ME; Mirzadegan T; Schmidt BF
    Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of bovine duodenase, a serine protease, with dual trypsin and chymotrypsin-like specificities.
    Pletnev VZ; Zamolodchikova TS; Pangborn WA; Duax WL
    Proteins; 2000 Oct; 41(1):8-16. PubMed ID: 10944388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional molecular modeling explains why catalytic function for angiotensin-I is different between human and rat chymases.
    Yamamoto D; Shiota N; Takai S; Ishida T; Okunishi H; Miyazaki M
    Biochem Biophys Res Commun; 1998 Jan; 242(1):158-63. PubMed ID: 9439628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
    Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
    J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
    Liao Y; Husain A
    Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile.
    Andersson MK; Enoksson M; Gallwitz M; Hellman L
    Int Immunol; 2009 Jan; 21(1):95-104. PubMed ID: 19073880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
    Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
    J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional reconstitution of an active recombinant human chymase from Pichia pastoris cell lysate.
    Nakakubo H; Morita M; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
    Yeast; 2000 Nov; 16(15):1387-96. PubMed ID: 11054819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of HslUV complexed with a vinyl sulfone inhibitor: corroboration of a proposed mechanism of allosteric activation of HslV by HslU.
    Sousa MC; Kessler BM; Overkleeft HS; McKay DB
    J Mol Biol; 2002 May; 318(3):779-85. PubMed ID: 12054822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
    Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
    Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2.0 A crystal structure and substrate specificity of the KDEL-tailed cysteine endopeptidase functioning in programmed cell death of Ricinus communis endosperm.
    Than ME; Helm M; Simpson DJ; Lottspeich F; Huber R; Gietl C
    J Mol Biol; 2004 Mar; 336(5):1103-16. PubMed ID: 15037072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease.
    Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L
    Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity.
    Karlson U; Pejler G; Tomasini-Johansson B; Hellman L
    J Biol Chem; 2003 Oct; 278(41):39625-31. PubMed ID: 12900423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
    Bode W; Turk D; Karshikov A
    Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
    Reimer JM; Enoksson M; Samollow PB; Hellman L
    Mol Immunol; 2008 Apr; 45(7):2116-25. PubMed ID: 18022236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.